Cambridge Investment Research Advisors’s Medifast MED Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-2,311
| Closed | -$213K | – | 3220 |
|
2023
Q2 | $213K | Sell |
2,311
-99
| -4% | -$9.13K | ﹤0.01% | 2822 |
|
2023
Q1 | $250K | Buy |
+2,410
| New | +$250K | ﹤0.01% | 2643 |
|
2022
Q4 | – | Sell |
-2,607
| Closed | -$283K | – | 3170 |
|
2022
Q3 | $283K | Buy |
2,607
+305
| +13% | +$33.1K | ﹤0.01% | 2409 |
|
2022
Q2 | $416K | Buy |
2,302
+814
| +55% | +$147K | ﹤0.01% | 2104 |
|
2022
Q1 | $254K | Buy |
1,488
+64
| +4% | +$10.9K | ﹤0.01% | 2681 |
|
2021
Q4 | $298K | Sell |
1,424
-232
| -14% | -$48.6K | ﹤0.01% | 2532 |
|
2021
Q3 | $319K | Buy |
1,656
+329
| +25% | +$63.4K | ﹤0.01% | 2408 |
|
2021
Q2 | $375K | Buy |
1,327
+83
| +7% | +$23.5K | ﹤0.01% | 2291 |
|
2021
Q1 | $263K | Buy |
1,244
+83
| +7% | +$17.5K | ﹤0.01% | 2381 |
|
2020
Q4 | $228K | Buy |
+1,161
| New | +$228K | ﹤0.01% | 2373 |
|
2020
Q1 | – | Sell |
-6,611
| Closed | -$724K | – | 2405 |
|
2019
Q4 | $724K | Buy |
6,611
+33
| +0.5% | +$3.61K | 0.01% | 1343 |
|
2019
Q3 | $682K | Sell |
6,578
-182
| -3% | -$18.9K | 0.01% | 1298 |
|
2019
Q2 | $867K | Buy |
6,760
+108
| +2% | +$13.9K | 0.01% | 1101 |
|
2019
Q1 | $848K | Sell |
6,652
-443
| -6% | -$56.5K | 0.01% | 1124 |
|
2018
Q4 | $887K | Sell |
7,095
-854
| -11% | -$107K | 0.01% | 1000 |
|
2018
Q3 | $1.76M | Buy |
7,949
+122
| +2% | +$27K | 0.02% | 738 |
|
2018
Q2 | $1.25M | Buy |
7,827
+319
| +4% | +$51.1K | 0.01% | 866 |
|
2018
Q1 | $702K | Buy |
7,508
+1,701
| +29% | +$159K | 0.01% | 1136 |
|
2017
Q4 | $405K | Sell |
5,807
-106
| -2% | -$7.39K | ﹤0.01% | 1444 |
|
2017
Q3 | $351K | Buy |
5,913
+741
| +14% | +$44K | ﹤0.01% | 1466 |
|
2017
Q2 | $214K | Sell |
5,172
-1
| -0% | -$41 | ﹤0.01% | 1713 |
|
2017
Q1 | $230K | Buy |
5,173
+91
| +2% | +$4.05K | ﹤0.01% | 1541 |
|
2016
Q4 | $212K | Buy |
+5,082
| New | +$212K | ﹤0.01% | 1471 |
|